- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00873054
Percutaneous Nephrolithotomy Versus Extracorporeal Shock Wave Lithotripsy
January 30, 2014 updated by: Samuel Deem, DO, CAMC Health System
The investigators main hypothesis is that the stone free rate will be much higher (95%) in patients treated with PCNL than patients treated with ESWL where stone free rate is (60%) to determine which treatment is safe and prevent less stone recurrence.
Study Overview
Status
Completed
Conditions
Detailed Description
Extracorporeal shock wave lithotripsy is preferred for small stones less than 10 mm in size.
Percutaneous nephrolithotomy is the standard therapy used for large kidney stones greater than 20 millimeters or stones in the lower kidney.
For moderate sized kidney stone (10-20 mm),currently the options for treatment include both methods.
However, no studies have proven that one procedure is better than the other.
So, we will compare both the procedures for breaking the kidney stone.
Our main outcome measures will be the stone-free status after the procedure.
Other outcome measures are assessment of morbidity associated with use of the procedures i.e. any minor or major complications within 3 months of initial treatment.
Patient will be assessed for infection at post-operative office visits to include a basic urinalysis only if they have systemic indicators of infection (fever, dysuria, frequency, etc.).
Pain will be monitored with the scale of 0-10 points.
Also we will review of stone density on Computerized Tomography (CT) scans and the effect this has on success of both procedures.
We hope with PCNL stone-free rates will be minimum with minimal morbidity and ultimately improve patient care.
Study Type
Observational
Enrollment (Actual)
32
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
West Virginia
-
Charleston, West Virginia, United States, 25301
- Urology center of charleston
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 90 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
Community patients who present to Charleston Area Medical Center (CAMC) or the private urology clinics of Drs.
Tierney, Martinez or Davalos with kidney stones between 10 and 20 mm in size would be screened based on inclusion criteria for possible enrollment in the study.
Description
Inclusion Criteria:
- Patients of both sex with age greater than 18 years to 90 years
- Stone burden between 10 and 20 mm diagnosed by CT scan
- Patient must be agreeable to randomization between shock wave lithotripsy and percutaneous stone removal
Exclusion Criteria:
- Patients with bleeding diathesis or taking anti-platelet or anti-coagulant medication
- Patients who are pregnant based on routine pre-operative pregnancy testing
- Patients with skin to stone size greater than 12 cm (measured routinely on CT scan)
- Patients with either Horseshoe kidney, transplant kidney or a solitary kidney
- Patients with ureteral calculi
- Patients with stone size of < 10 mm and > 20 mm
- Ureteropelvic junction obstruction
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Case-Only
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
---|
1 ESWL
In this procedure,scope will be placed inside bladder and a plastic tube (stent) will be left to drain the kidney on the affected side in a routine manner.
Next the patient will be transferred to a separate room and sound waves will be aimed at the center of the stone until the stone is broken into pieces.
|
2 PCNL
In this procedure,scope will be placed inside bladder and a plastic tube (stent) will be left to drain the kidney on the affected side in a routine manner.
Next, a small (1cm) cut will be made in the back and a tube will be placed into the kidney.
Through this tube a small camera will be placed inside the kidney and break the stone into many pieces and remove them through the same tube.
All fragments that can be seen will be removed.
A different plastic tube (drain) will be placed through the cut and into the kidney and left in place for 5-7 days.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
The primary objective of this study is to compare the stone-free status after Extracorporeal Shock Wave Lithotripsy (ESWL) and Percutaneous Nephrolithotomy (PCNL) for kidney stones 10-20 mm in size.
Time Frame: Within 3 months of enrollment
|
Within 3 months of enrollment
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
A secondary objective is to assess the morbidity associated with use of the procedures i.e. any minor or major complications within 3 months of initial treatment.
Time Frame: Within 3 months of enrollment
|
Within 3 months of enrollment
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Julio G. Davalos, MD, CAMC Medical Staff - with admitting privileges
- Principal Investigator: Frederick Martinez, M.D., CAMC Medical Staff - with admitting privileges
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
October 1, 2008
Primary Completion (Actual)
October 1, 2010
Study Completion (Actual)
January 1, 2011
Study Registration Dates
First Submitted
March 31, 2009
First Submitted That Met QC Criteria
March 31, 2009
First Posted (Estimate)
April 1, 2009
Study Record Updates
Last Update Posted (Estimate)
February 3, 2014
Last Update Submitted That Met QC Criteria
January 30, 2014
Last Verified
January 1, 2014
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 08-08-2078
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Kidney Stones
-
Indiana Kidney Stone InstituteUniversity of Washington; VA Puget Sound Health Care SystemCompleted
-
Omeros CorporationCompletedUrinary Calculi | Renal Calculi | Kidney Stones | Urinary Stones | Urinary Tract StonesUnited States
-
Mayo ClinicCompletedKidney Calculi | Nephrolithiasis | Kidney Stones | Renal StonesUnited States, Canada
-
United States Naval Medical Center, San DiegoUnknown
-
University of British ColumbiaPercutaneous Systems, Inc.Completed
-
Robert SworWilliam Beaumont HospitalsCompletedKidney Stones | Ureteral StonesUnited States
-
Mansoura UniversityUnknownUrologic Diseases | Stones, Kidney | Stone, Urinary | Shock Wave LithotripsyEgypt
-
Mansoura UniversityRecruitingUrinary Stones | Renal StoneEgypt
-
Services Hospital, LahoreCompleted
-
Adva-TecUniversity of British ColumbiaCompletedUnilateral Ureteral Stone | Renal Stone Fragments ≤ 2mmCanada